1. Baudot P, Jaque M, Robin M (1977) Effect of a diazo-polyoxamacroobicyclic complexing agent on the urinary elimination of lead in lead-poisened rats. Toxicol Appl Pharmacol 41: 113–115
2. Baumann M, Schäfer E, Grein H (1984) Short term studies with the cryptating agent hexaoxa-diaza-bicyclo-hexacosane in rats. Arch Toxicol 55 [Suppl 7]: 427–429
3. Dowd MT, Chin-Tu C, Wendel MJ, Faulhaber PJ, Cooper MD (1991) Radiation dose to the bladder wall from 2-(l8F) fluoro-2-desoxy-D-glucose in adult humans. J Nucl Med 32: 707–712
4. European Pharmacopoeia (1996) Radiopharmaceutical preparations, pp 1424–1433
5. Gallagher BM, Ansari A, Atkins H et al. (1977) Radiopharmaceuticals XXVII. 18F-labeled 2-desoxy-2-fluoro-D-glu-cose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med 18: 990–996